A comprehensive study in The Lancet reveals the global health impacts of 88 risk factors, emphasizing the significant burden of air pollution and high blood pressure.
Taking health in our own hands indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Idorsia Pharmaceuticals Ltd: JERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant hypertension finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Ad hoc announcement pursuant to Art. 53 LR Idorsia receives a positive opinion from the Committee for Medicinal Products for Human Use for JERAYGO™ as the first and only endothelin receptor.